Lmt Avocats advises Susbtipharm
Lmt Avocats advised SUBSTIPHARM, a private pharmaceutical group, on the acquisition of EVISTA product in certain territories from the American group Eli Lilly. Evista is a pharmaceutical drug used in the treatment and prevention of Ostoporosis.
Our team was led by Cristian Rawlins, with the support of Arnaud Gundermann.